Cargando…

The role of enkephalinergic systems in substance use disorders

Enkephalin, an endogenous opioid peptide, is highly expressed in the reward pathway and may modulate neurotransmission to regulate reward-related behaviors, such as drug-taking and drug-seeking behaviors. Drugs of abuse also directly increase enkephalin in this pathway, yet it is unknown whether or...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rysztak, Lauren G., Jutkiewicz, Emily M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9391026/ https://www.ncbi.nlm.nih.gov/pubmed/35993087 http://dx.doi.org/10.3389/fnsys.2022.932546

Ejemplares similares

Prefrontal Dopaminergic and Enkephalinergic Synaptic Accommodation in HIV-associated Neurocognitive Disorders and Encephalitis
por: Gelman, Benjamin B., et al.
Publicado: (2012)

Differential regulation of morphine antinociceptive effects by endogenous enkephalinergic system in the forebrain of mice
por: Chen, Tsung-Chieh, et al.
Publicado: (2008)

Freezing of Enkephalinergic Functions by Multiple Noxious Foci: A Source of Pain Sensitization?
por: Cesselin, François, et al.
Publicado: (2009)

Delta Opioid Receptors and Enkephalinergic Signaling within Locus Coeruleus Promote Stress Resilience
por: Tkaczynski, John A., et al.
Publicado: (2022)

The Gut Microbiome and Substance Use Disorder
por: Russell, Jordan T., et al.
Publicado: (2021)

The Primacy of Cognition in the Manifestations of Substance Use Disorders
por: Cadet, Jean Lud, et al.
Publicado: (2013)

Drug Design Targeting the Muscarinic Receptors and the Implications in Central Nervous System Disorders
por: Johnson, Chad R., et al.
Publicado: (2022)

Mini-review: The neurobiology of treating substance use disorders with classical psychedelics
por: Urban, Marvin M., et al.
Publicado: (2023)

Neuroimmune Mechanisms as Novel Treatment Targets for Substance Use Disorders and Associated Comorbidities
por: Namba, Mark D., et al.
Publicado: (2021)

Editorial: Sleep and circadian rhythm disruptions associated with substance use disorders
por: Berro, Lais F., et al.
Publicado: (2023)

The Use of Virtual Reality in Craving Assessment and Cue-Exposure Therapy in Substance Use Disorders
por: Hone-Blanchet, Antoine, et al.
Publicado: (2014)

Regulation of Adult Neurogenesis by Non-coding RNAs: Implications for Substance Use Disorders
por: Oliver, Robert J., et al.
Publicado: (2018)

Reduced Functional Connectivity within the Mesocorticolimbic System in Substance Use Disorders: An fMRI Study of Puerto Rican Young Adults
por: Posner, Jonathan, et al.
Publicado: (2016)

Mechanisms of Shared Vulnerability to Post-traumatic Stress Disorder and Substance Use Disorders
por: María-Ríos, Cristina E., et al.
Publicado: (2020)

Brain activity classifies adolescents with and without a familial history of substance use disorders
por: Qiao, Jianping, et al.
Publicado: (2015)

Altered expression of somatostatin signaling molecules and clock genes in the hippocampus of subjects with substance use disorder
por: Valeri, Jake, et al.
Publicado: (2022)

Effects of dose on acquisition and persistence of a new response for a remifentanil-associated stimulus
por: Robertson, Stephen H., et al.
Publicado: (2020)

The IntelliCage System: A Review of Its Utility as a Novel Behavioral Platform for a Rodent Model of Substance Use Disorder
por: Iman, Ismail Nurul, et al.
Publicado: (2021)

Stress as a Risk Factor for Substance Use Disorders: A Mini-Review of Molecular Mediators
por: Mukhara, Deepika, et al.
Publicado: (2018)

Combining noninvasive brain stimulation with behavioral pharmacology methods to study mechanisms of substance use disorder
por: Wesley, Michael J., et al.
Publicado: (2023)

Post Traumatic Stress Disorder and Substance Use Disorder as Two Pathologies Affecting Memory Reactivation: Implications for New Therapeutic Approaches
por: Gisquet-Verrier, Pascale, et al.
Publicado: (2019)

Friend of the Devil: Negative Social Influences Driving Substance Use Disorders
por: Pomrenze, Matthew B., et al.
Publicado: (2022)

The role of the GABA system in amphetamine-type stimulant use disorders
por: Jiao, Dongliang, et al.
Publicado: (2015)

The role of Effortful Control in Substance Use Disorders
por: Santens, E., et al.
Publicado: (2022)

Drug-Induced Conditioned Place Preference and Its Practical Use in Substance Use Disorder Research
por: McKendrick, Greer, et al.
Publicado: (2020)

The Therapeutic Potential of Targeting Substance P/NK-1R Interactions in Inflammatory CNS Disorders
por: Johnson, M. Brittany, et al.
Publicado: (2017)

Cox Regression Based Modeling of Functional Connectivity and Treatment Outcome for Relapse Prediction and Disease Subtyping in Substance Use Disorder
por: Zhai, Tianye, et al.
Publicado: (2021)

Conflicting theories on addiction aetiology and the strengths and limitations of substance use disorder disease modelling
por: Greener, Megan R., et al.
Publicado: (2023)

The Role of Substance P in Secondary Pathophysiology after Traumatic Brain Injury
por: Vink, Robert, et al.
Publicado: (2017)

The Predictive Value of Impulsivity and Risk-Taking Measures for Substance Use in Substance Dependent Offenders
por: Rieser, Nathalie M., et al.
Publicado: (2019)

Biomarkers of the Endocannabinoid System in Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2022)

Nanoparticle delivery systems for substance use disorder
por: Kasina, Vishal, et al.
Publicado: (2022)

The Role of Gamma Oscillations in the Pathophysiology of Substance Use Disorders
por: Ramlakhan, Jessica U., et al.
Publicado: (2020)

Environmental Enrichment Modulates Drug Addiction and Binge-Like Consumption of Highly Rewarding Substances: A Role for Anxiety and Compulsivity Brain Systems?
por: Rodríguez-Ortega, Elisa, et al.
Publicado: (2018)

A survey of substance use for cognitive enhancement by university students in the Netherlands
por: Schelle, Kimberly J., et al.
Publicado: (2015)

The potential therapeutic roles of Rho GTPases in substance dependence
por: Ru, Qin, et al.
Publicado: (2023)

Editorial: Neural pathophysiological mechanisms of neuropsychiatric disorders underlying substance abuse
por: Wang, Zhuo, et al.
Publicado: (2023)

Potassium Channels and Their Potential Roles in Substance Use Disorders
por: McCoy, Michael T., et al.
Publicado: (2021)

Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
por: Navarrete, Francisco, et al.
Publicado: (2021)

The Roles of Lpar1 in Central Nervous System Disorders and Diseases
por: Xiao, Dongqiong, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2llb7b8hu9j9cnbr3slm23fvg7